Our innovative DEL-AI platform and leadership in the protein degradation field have attracted partnerships with industry-leading pharmaceutical companies. Together, we’re accelerating the development of novel therapies across a diverse range of disease areas for patients.
Trusted partners in targeted protein degradation
Chief Business Officer
As a deeply scientific organization, we seek strategic partners who share our commitment to rigorous innovation and our belief in the promise of targeted protein degradation to change the course of disease for patients and their families.
A philosophy of collaboration to advance breakthrough science
We believe targeted protein degradation has the potential to outmatch disease, and realizing that potential can be accelerated by the right collaborations. We seek partners who bring complementary expertise, bold thinking, and a commitment to translating breakthrough biology into meaningful therapeutic impact.
